HITACHI ALOKA MEDICAL, LTD. – Trademark Portfolio
Entity Type: 03
HITACHI ALOKA MEDICAL, LTD. holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 16 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include ALOKA, MYDOSE, ARIETTA, LISENDO, and ACCUFLEX. The owner is based in TOKYO.
6-22-1 MURE, MITAKA-SHI
TOKYO , JP
Showing of trademarks Trademarks
Trademark Classifications
HITACHI ALOKA MEDICAL, LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does HITACHI ALOKA MEDICAL, LTD. have?
HITACHI ALOKA MEDICAL, LTD. has 26 U.S. trademarks filed with the USPTO. Of these, 7 registered, 5 abandoned, 12 cancelled.
What trademark classes does HITACHI ALOKA MEDICAL, LTD. file in?
HITACHI ALOKA MEDICAL, LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are HITACHI ALOKA MEDICAL, LTD.'s most well-known trademarks?
HITACHI ALOKA MEDICAL, LTD.'s registered trademark portfolio includes well-known marks such as ALOKA, MYDOSE, ARIETTA, LISENDO, and ACCUFLEX. These are among 7 currently registered trademarks in the portfolio.
What is HITACHI ALOKA MEDICAL, LTD.'s trademark registration success rate?
HITACHI ALOKA MEDICAL, LTD. has a 29% trademark registration rate, with 7 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.